Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Established Safety Profile# Recommendation : CagriSema Reason : Builds on semaglutide's 7+ year post-marketing safety record and over 25,000 clinical trial participants
The ad is a clear violation of the Federal Food, Drug, and Cosmetic Act (FDCA), which requires that advertising for prescription drugsincluding compounded drugsnot be false or misleading. In addition, PhRMA admonished Hims & Hers for appearing to violate guidelines set by the Alliance for Pharmacy Compounding, which say non-FDA-approved drugs cant be promoted as safe and effective for treating a particular condition
or if they develop signs of more serious adverse effects such as severe abdominal pain (which may indicate pancreatitis), symptoms of gallbladder disease, visual changes, severe allergic reactions, or symptoms of thyroid nodules
Significant weight loss shown in clinical trials Helps control appetite and food cravings May improve blood sugar and insulin sensitivity FDA-approved for chronic weight management in eligible adults These benefits make Tirzepatide one of the best prescription options for overall weight loss
